Evidence map›Paper›PMID 33637726›Full record

ArticleNature communications2021

Combinatorial CRISPR screen identifies fitness effects of gene paralogues.

Nicola A Thompson, Marco Ranzani, Louise van der Weyden, Vivek Iyer, Victoria Offord, Alastair Droop, Fiona Behan, Emanuel Gonçalves, Anneliese Speak, Francesco Iorio and 12 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 2 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 2 syntheses or guidelines pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Uncovering cancer dependencies in peptide-interacting protein pockets.bioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 2 countries.

Nicola A ThompsonWellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
Marco Ranzani *Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
Louise van der Weyden *Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.ORCID 0000-0002-0645-1879
Vivek IyerWellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
Victoria OffordWellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
Alastair DroopWellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
Fiona BehanWellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.ORCID 0000-0002-9070-7688
Emanuel GonçalvesWellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.ORCID 0000-0002-9967-5205
Anneliese SpeakWellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.ORCID 0000-0003-4890-4685
Francesco IorioWellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.ORCID 0000-0001-7063-8913
James HewinsonWellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
Victoria HarleWellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
Holly RobertsonWellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
Elizabeth AndersonWellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
Beiyuan FuWellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
Fengtang YangWellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.ORCID 0000-0002-3573-2354
Guido Zagnoli-VieiraWellcome Trust/Cancer Research UK Gurdon Institute, Cambridge, UK.ORCID 0000-0002-5656-1056
Phil ChapmanCancer Research UK, Manchester Institute, Manchester, UK.
Martin Del Castillo Velasco-HerreraWellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
Mathew J GarnettWellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.ORCID 0000-0002-2618-4237
Stephen P JacksonWellcome Trust/Cancer Research UK Gurdon Institute, Cambridge, UK.ORCID 0000-0001-9317-7937
David J AdamsWellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK. da1@sanger.ac.uk.ORCID 0000-0001-9490-0306
Wellcome Sanger Institute · GBThe Gurdon Institute · GBCancer Research UK Manchester Institute · GB

Funding

Cancer Research UK 18796Cancer Research UK C6946/A24843Cancer Research UK C6/A18796Wellcome TrustWellcome Trust 206194Wellcome Trust 206388/Z/17/ZWellcome Trust WT203144
6 · The paper itself

Abstract

Genetic redundancy has evolved as a way for human cells to survive the loss of genes that are single copy and essential in other organisms, but also allows tumours to survive despite having highly rearranged genomes. In this study we CRISPR screen 1191 gene pairs, including paralogues and known and predicted synthetic lethal interactions to identify 105 gene combinations whose co-disruption results in a loss of cellular fitness. 27 pairs influence fitness across multiple cell lines including the paralogues FAM50A/FAM50B, two genes of unknown function. Silencing of FAM50B occurs across a range of tumour types and in this context disruption of FAM50A reduces cellular fitness whilst promoting micronucleus formation and extensive perturbation of transcriptional programmes. Our studies reveal the fitness effects of FAM50A/FAM50B in cancer cells.

Indexed as

Clustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsGenomeAnimalsApoptosisCell Line, TumorDNA-Binding ProteinsGene Knockout TechniquesHeterograftsHumansMiceMice, Inbred NODMice, SCIDProteinsRNA-Binding ProteinsTranscriptomeDNA-Binding ProteinsFAM50A protein, humanFAM50B protein, humanProteinsRNA-Binding Proteins

Identifiers

PMID33637726
PMCPMC7910459
OpenAlexW3132758757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.